SCHEMBL26590801

SCHEMBL26590801

CNC1CN(c2ncc(-c3cc4c5c(cnc4cc3F)N(C)C(=O)C53CCC3)cc2NSN(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRKDC P78527 3/20 0.52
▸ ATM Q13315 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26590804 0.90 PRKDC (0.53) PRKDCATM
SCHEMBL26130673 0.89 PRKDC (0.56) PRKDCATM
SCHEMBL29969735 0.89 PRKDC (0.56) PRKDCATM
SCHEMBL21512997 0.88 PRKDC (0.65) PRKDCATM
SCHEMBL26129958 0.87 PRKDC (0.59) PRKDCATM
SCHEMBL29968330 0.86 PRKDC (0.57) PRKDCATM
SCHEMBL21513447 0.86 PRKDC (0.57) PRKDCATM
Formic Acid SCHEMBL29970588 0.84 PRKDC (0.61) PRKDCATM
Formic Acid SCHEMBL26131024 0.84 PRKDC (0.61) PRKDCATM
SCHEMBL29968075 0.82 PRKDC (0.56) PRKDCATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327877-A2 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2024-02-28 — — EP disclosed
EP-3784671-B1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS INC (US) 2023-10-11 — — EP disclosed
Send feedback